Clinical trial · Interventional
Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma
Multi-Center Clinical Trial of Uterine Artery Embolization Treatment of Uterine Leiomyoma
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The efficacy and safety of uterine artery embolization, as compared with standard surgical methods, for the treatment of symptomatic uterine fibroids remain uncertain. The purpose of this trial is to evaluate the uterine volume and tumor size reduction, symptomatic relief, complication, fertility, ovarian function and quality of life with uterine artery embolization for uterine fibroids comparing with standard surgical methods.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Leiomyoma | Leiomyoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Interventional radiological or surgical management | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- pregnancy expectation
- description
- The patients who desire for future pregnancy will enroll into this arm , and will be divided into UAE group and SURGERY group.
- interventionNames
- Procedure: Interventional radiological or surgical management
- type
- ACTIVE_COMPARATOR
- label
- No pregnancy expectation
- description
- The patients who don't desire for reserving uterus and/ or future pregnancy will enroll into this arm , and will be divided into UAE group and SURGERY group.
- interventionNames
- Procedure: Interventional radiological or surgical management
Primary outcomes (2)
- measure
- quality of life
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 50 Years
Show eligibility criteria text
Inclusion Criteria: * Clinical diagnosis of symptomatic uterine leiomyoma Exclusion Criteria: * pregnancy * iodine agent allergy * patient refuse to take part in this trial * tumour size is less than 3cm or beyond 10cm * with endometriosis * with malignant diseases * with abnormal coagulation function which can't restore * with acute inflammatory diseases or acute episode of chronic inflammatory diseases * with severe heart, lung, liver and kidney, et al. organ diseases.
References
Publications (0)
Data not yet available